Condition:   Arthritis, Juvenile Idiopathic
Interventions:   Biological: Double-Blind Adalimumab/Placebo + MTX;   Biological: Double-Blind Adalimumab/Placebo;   Drug: OLE BSA Adalimumab +/- MTX;   Drug: OLE FD Adalimumab +/- MTX
Sponsor:   Abbott
Completed - verified August 2011